文献速递其他结缔组织病

抗磷脂综合征的流行病学研究:基于人群的队列分析

The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study.
PubMed 文献 · Arthritis Rheumatol · 2019-08-01

该研究基于2000-2015年明确地理区域人群的医疗记录,识别33例符合2006年悉尼标准的新发抗磷脂综合征(APS)患者,估算年发病率为2.1/10万(95%CI 1.4-2.8),估计患病率为50/10万(95%CI 42-58),死亡率与一般人群无显著差异(标准化死亡比1.61,95%CI 0.74-3.05)。

要点

  • APS年发病率约2.1/10万,男女相似,平均年龄54.2岁。
  • 估计患病率为50/10万,男女相似。
  • 死亡率与一般人群无显著差异(SMR 1.61,95%CI 0.74-3.05)。

核心结论

  • APS年发病率约2人/10万,估计患病率50/10万,总体死亡率与一般人群无显著差异。

研究设计与样本

  • 基于2000-2015年明确地理区域人群的起始队列,通过全面个体医疗记录审查识别病例,以2006年悉尼标准为主要定义。

主要发现

  • 共识别33例符合悉尼标准的新发APS患者,平均年龄54.2岁,55%女性,97%白人。
  • 成人(≥18岁)年发病率为2.1/10万(95%CI 1.4-2.8),男女发病率相似。
  • 估计患病率为50/10万(95%CI 42-58),男女相似。
  • 6例(18%)合并系统性红斑狼疮,最常见临床表现为深静脉血栓。
  • 总死亡率与一般人群无显著差异(标准化死亡比1.61,95%CI 0.74-3.05)。

关键数值与推荐

  • 采用2006年悉尼标准作为APS主要定义,次要定义需医师共识确认。
  • 集中实验室检测狼疮抗凝物、IgM和IgG抗心磷脂抗体及抗β2-糖蛋白I抗体。
  • 发病率按2010年美国白人人口进行年龄和性别调整。

临床怎么用

  • 临床遇到疑似APS患者时,可参考年发病率约2.1/10万、患病率约50/10万的人群负担数据。
  • 诊断应依据2006年悉尼标准并结合集中实验室检测抗体。

局限性

  • 患病率估算假设无APS相关死亡率增加且迁移与疾病状态无关。
  • 队列中97%为白人,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS). METHODS: An inception cohort of patients with incident APS in 2000-2015 from a geographically well-defined population was identified based on comprehensive individual medical records review. All cases met the 2006 Sydney criteria for APS (primary definition) or had a diagnosis of APS confirmed by physician consensus (secondary definition). Levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies, and anti-β2-glycoprotein I antibodies were tested in a centralized laboratory. Incidence rates were age- and sex-adjusted to the 2010 US white population. Prevalence estimates were obtained from the incidence rates, assuming that there was no increased mortality associated with APS and that migration in or out of the area was independent of disease status. RESULTS: Among this cohort in 2000-2015, 33 cases of incident APS, as defined by the Sydney criteria, were identified (mean age of patients 54.2 years; 55% female, 97% white). The annual incidence of APS in adults ages ≥18 years was 2.1 (95% confidence interval [95% CI] 1.4-2.8) per 100,000 population. Incidence rates were similar in both sexes. The estimated prevalence of APS was 50 (95% CI 42-58) per 100,000 population, and was similar in both sexes. Six patients (18%) had a concurrent diagnosis of systemic lupus erythematosus. The most frequent clinical manifestation was deep vein thrombosis. The overall frequency of mortality among patients with APS was not significantly different from that in the general population (standardized mortality ratio 1.61, 95% CI 0.74-3.05). CONCLUSION: APS occurred in ~2 persons per 100,000 population per year. The estimated prevalence was 50 per 100,000 population. Overall mortality was not notably different from that observed in the general population.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Duarte-García A, Pham MM, Crowson CS, et al. The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study. Arthritis Rheumatol. 2019. PMID: 30957430. doi:10.1002/art.40901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。